期刊文献+

人源抗狂犬病毒基因工程单链抗体的研究 被引量:1

Generation of recombinant human ScFv antibodies against Rabies virus
原文传递
导出
摘要 目的研制人源抗狂犬病毒基因工程抗体。方法从具有高滴度狂犬病毒抗体的疫苗接种者采集外周血淋巴细胞,通过pHAL14载体和高效噬菌体系统构建人源抗狂犬病毒单链基因工程抗体库,经纯化的狂犬病毒aG株富集筛选,通过ELISA和IFA鉴定阳性抗体克隆并进行序列测定。利用IgG表达载体VH/VK双质粒系统瞬时转染293T细胞实现IgG抗体的分泌型表达,通过亲和力测定和中和试验鉴定IgG抗体功能。结果成功地获得了6株抗狂犬病毒糖蛋白的人源单克隆抗体,非竞争ELISA显示6株抗体具有较高的亲和力,体外中和试验证实这6株人源单抗对狂犬病毒C^S株无中和活性,对aG株具有较强的中和活性。结论从免疫库中获得了6株人源单克隆抗体,为狂犬病毒的鉴别诊断和治疗奠定了基础。 Objective To obtain recombinant human anti-rabies antibodies by antibody phage library approach. Methods A combinatorial ScFv antibody phage library was constructed using pHAL14 vector from the peripheral blood of volunteers after rabies immunization. After package by hyperphage, the ScFv phage library was panned and selected by ELISA and IFA with purified rabies virus aG strain. The specific antibody was converted to full human IgG antibody with the VH Express and VK Express cassettes. Affinity and neutralizing test were performed to verify the function of the IgG molecules. Results Six unique human ScFv antibodies specific for the glyeoprotein of rabies virus were obtained by ELISA, IFA and DNA sequencing. The full human IgG antibodies with high affinity represented a high level neutralizing activity to rabies virus aG strain, but not CVS strain. Conclusion The obtained human anti-rabies antibodies are important for diagnosis and treatment of rabies virus infection.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2012年第3期189-192,共4页 Chinese Journal of Experimental and Clinical Virology
基金 国家863计划(2009AA022109)
关键词 狂犬病病毒 免疫球蛋白类 重链 免疫球蛋白类 轻链 噬菌体 Rabies virus Immunoglobulins, heavy-chain Immunoglobulins, light-china Phages
  • 相关文献

参考文献8

  • 1俞永新.狂犬病和狂犬病疫苗[M]北京:中国医药科技出版社,20017-41.
  • 2Lyles DS,Rupprecht CE. Rhabdoviridae[A].Philadelphia,PA:Lippincott Williams & Wilkins,2007.1363-1408.
  • 3World Health Organization. WHO Expert Consultation on Rabies.[1st report.WHO Technical Report Series,No.931.][R].Geneva,Switzerland:World Health Organization,2005.
  • 4Goudsmit J,Marissen W E,Weldon W C. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin[J].Journal of Infectious Diseases,2006.796-801.
  • 5Hust M,Toleikis L,Dubel S. Antibody phage display[A].Weinheim:Wiley-VCH,2007.45-68.
  • 6Rondot S,Koch J,Breitling F. A helper phage to improve single-chain antibody presentation in phage display[J].Nature Biotechnology,2001.75-78.
  • 7Bakker AB,Python C,Kissling C J. First administration to humans of a monoclonal antibody cocktail against rabies virus:safety,tolerability,and neutralizing activity[J].Vaccine,2008.5922-5927.
  • 8陈哲,孙丽娜,李川,吕新军,唐青,梁米芳,李德新.人源中和性抗狂犬病毒基因工程抗体的研制[J].病毒学报,2010,26(4):271-275. 被引量:7

二级参考文献6

  • 1Knobel D L, Cleaveland S, Coleman P G, et al. Re-evaluating the burden of rabies in Africa and Asia[J]. Bull World Health Organ, 2005, 83: 360-368.
  • 2Goudsmit J, Marissen W E, Weldon W C, et al. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin[J]. J Infect Dis, 2006, 193(6).. 796-801.
  • 3Barbas C F, Kang A S, larner R A. Assembly of combinatorial antibody libraries on phage surface: the gene III site[J]. Proc Natl Acad Sei USA, 1991, 88(18) : 7978- 7982.
  • 4Liang M F, Stefan D, Li D X, et al. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments[J]. J Immunol Meth, 2001, 247: 119-130.
  • 5Harlow E, Lane D. Antibodies: A Laboratory Manual [M]. New York: Cold Spring Harbor Laboratory Press, 1988.
  • 6Bakker A B, Python C, Kissling C J, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity[J]. Vaccine, 2008, 26(47): 5922-5927.

共引文献6

同被引文献8

  • 1World Health Organization.Strategies for the control and elimination of rabies in Aisa[M].Geneva,Switzerland,2001,2.
  • 2SunL N,ChenZ,YuL,et al.Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein[J].Appl Microbiol Biotechnol,2012,96(2):357-366.
  • 3HustM,ToleikisL,DubelS.Antibody phage display.Handbook of therapeutic antibodies[M].Weinheim:Wiley-VCH,2007:45-68.
  • 4PelatT,HustM,LafflyE,et al.High-affinity,human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation[J].Antimicro Agents Chemother,2007,51(8):2758-2764.
  • 5BeattyJD,BarbaraG.Beatty,William G.Vlahos.Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay[J].J Immunol Methods,1987,100(1-2):173-179.
  • 6BakkerAB1,PythonC,KisslingCJ,PandyaP,et al.First administration to humans of a monoclonal antibody cocktail against rabies virus:safety,tolerability,and neutralizing activity[J].Vaccine,2008,26(47):5922-5927.
  • 7ZanettiM.Antigenized antibodies[J].Nature,1992,355 (6359):476-477.
  • 8陈哲,孙丽娜,李川,吕新军,唐青,梁米芳,李德新.人源中和性抗狂犬病毒基因工程抗体的研制[J].病毒学报,2010,26(4):271-275. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部